Optimize
Quarterly Rebalancing
EUR
High Risk
2.2yr backtest

Performance Summary

Total Return+68.25%
Annualized Return+26.26%
Volatility+22.29%
Sharpe Ratio1.09
Max Drawdown+29.30%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
A diversified global equity ETF portfolio targeting technology, US growth, semiconductors, clean energy, and healthcare innovation.
AssetTypeAllocationTER
XDWT.XETRA
Xtrackers MSCI World Information Technology UCITS ETF 1CIE00BM67HT60
ETF
40.0%0.25%
QGRW.XETRA
WisdomTree US Quality Growth UCITS ETF USD Unhedged AccIE000YGEAK03
ETF
40.0%0.33%
VVSM.XETRA
VanEck Semiconductor UCITS ETFIE00BMC38736
ETF
10.0%0.35%
G1CE.XETRA
Invesco Global Clean Energy UCITS ETF AccIE00BLRB0242
ETF
5.0%0.6%
2B78.XETRA
iShares Healthcare Innovation UCITS ETFIE00BYZK4776
ETF
5.0%0.4%
Total100.0%0.32%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €16,825.25
Histogram of Monthly Returns
The portfolio had a positive return during 16 of the 28 months (57%)
Monthly Returns Heatmap
Best month: +16.8% • Worst month: -12.3% • Best year: 2024 (+26.1%) • Worst year: 2025 (+11.6%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-0.2%-2.4%-5.0%+16.8%+14.6%+0.5%-4.0%-----+19.6%
2025+1.5%-6.2%-12.3%-2.7%+10.8%+4.7%+7.9%-1.8%+6.2%+9.3%-3.4%-0.3%+11.6%
2024---+1.8%+3.8%+10.8%-3.8%-1.8%+1.7%+1.6%+7.1%+3.0%+26.1%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +29.30% • The longest drawdown period lasted for 8 months and was between January 2025 and September 2025. It reached a trough of -29.3%.

Detailed Metrics

Returns
Total Return
+68.25%
Annualized Return
+26.26%
Avg Monthly Return
+2.08%
Risk
Volatility (Annual)
+22.29%
Max Drawdown
+29.30%
Positive Months
57%
Average Drawdown
-6.3%
Risk-Adjusted
Sharpe Ratio
1.09
Risk-free rate: 2.0%
Sortino Ratio
1.00
Downside risk adjusted
Return/Volatility
1.18
Calmar Ratio
0.90
Return/Max Drawdown
Ulcer Index
7.82
Drawdown depth & duration
Martin Ratio
0.03
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
16,825.25
Backtest Period
2024-04-23 to 2026-07-17
2.2 years
Rebalancing
quarterly
Base Currency
EUR